Absolute Event Rate: 6.1% vs 19.7%
The actomyosin system plays a crucial role in Influenza A virus vRNP assembly and virion morphogenesis.
Myosin inhibition impairs influenza vRNP clustering in preclinical models; extends viral morphogenesis insights but leaves open therapeutic translation.
Influenza A virus encodes its genome in eight segments of viral ribonucleopropteins (vRNPs) replicated in the cell nucleus. Clustering of the eight vRNPs is thought to be a selective process promoted by negative-strand RNA interactions. Here, we visualized vRNP packaging at the plasma membrane using immuno-freeze-etching electron microscopy. After being transported to the inner surface of the plasma membrane, individual progeny vRNPs bound to actin filaments and clustered. Clustered vRNPs intermingled with actin filaments, myosin-II and the viral matrix protein M1, as shown by immunocytochemistry. Inhibition of myosin function by blebbistatin prevented proper vRNP clustering. Live-cell high-speed atomic force microscopy revealed blebbistatin reduced the budding kinetics of virions. Our findings highlight the importance of the actomyosin system in vRNP assembly and virion morphogenesis.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2023) studied Influenza A virus infection. Blebbistatin vs. Control (absence of blebbistatin) was evaluated on Distribution density of vRNP clusters containing five or more anti-vRNP antibody labels on the inner surface of the plasma membrane.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: